Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 241 to 255 of 337 results for antibiotics

  1. Preterm prelabour rupture of membranes: What are the relative risks and benefits of induced labour versus expectant management in women whose membranes have ruptured spontaneously between 34 and 37 weeks?

    membranes have ruptured, avoiding the need for induction. The value of antibiotic therapy and the administration of corticosteroids to...

    Research recommendation
    Published
    15 December 2021

  2. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  3. Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related quality of life of the baby's family?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  4. Risk factors for and clinical indicators of early-onset infection: What is the risk of early-onset neonatal infection with maternal obesity and how does this change with increasing body mass index?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  5. Risk factors for and clinical indicators of early-onset infection: What is the accuracy of clinical prediction models for early-onset neonatal infection in the UK and what is their effectiveness in guiding management in the baby?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  6. Risk factors for and clinical indicators of late-onset infection: What is the accuracy of new or existing clinical prediction models for late-onset neonatal infection in the UK and what is their effectiveness in guiding management: - for babies already on a neonatal unit? - for babies admitted from home?

    guidance details Comes from guidance Neonatal infection: antibiotics for prevention and treatment Number NG195 Date issued

    Research recommendation
    Published
    6 August 2021

  7. Saving babies' hearing: how a world-first rapid genetic test is transforming neonatal care

    Learn how NICE's healthtech guidance helped bring life-changing genetic testing to neonatal units across the UK, saving 20 babies' hearing so far with potential to prevent hearing loss in 200 babies annually.

    News
    Last updated
    23 March 2026

  8. Cerebral palsy in under 25s: assessment and management (NG62)

    This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible.

    NICE guideline
    Published
    25 January 2017
    View recommendations

    Sections for NG62

  9. Identifying infection in women with preterm prelabour rupture of membranes (P-PROM):- What is the diagnostic accuracy of serial C-reactive protein testing to identify chorioamnionitis in women with P-PROM?

    of infection allows consideration of therapeutic strategies (including antibiotics and/or early birth). Effective treatment of infection...

    Research recommendation
    Published
    11 December 2015

  10. Antimicrobial stewardship

    All NICE products on antimicrobial stewardship. Includes any guidance, advice and quality standards.

    Topic page

  11. myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

    NICE has developed a medtech innovation briefing (MIB) on myAIRVO2 for the treatment of chronic obstructive pulmonary disease .

    Medtech innovation briefing
    Published
    1 October 2018

  12. High-risk groups:- What interventions to prevent infection and reduce antimicrobial resistance are effective for groups of people at high risk of infection? This includes people who:- have suppressed immune systems (for example, because of HIV, an inherited condition or treatment they may be having for conditions such as cancer or an organ transplant)- have a chronic disease- live in crowded conditions (see Shelter's definition)- are homeless- have been in prison- have migrated from countries with a high prevalence of infectious diseases such as tuberculosis (examples include South Asia and sub-Saharan Africa).

    strains. Interventions for these groups have focused on reducing the use of antibiotics for respiratory illnesses. More interventions...

    Research recommendation
    Published
    17 February 2017

  13. Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (HTG375)

    Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.

    HealthTech guidance
    Published
    26 June 2015
    View recommendations

    Sections for HTG375

  14. Optilume for anterior urethral strictures (MIB241)

    NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures .

    Medtech innovation briefing
    Published
    5 January 2021

  15. Acute hepatic encephalopathy:- In people with cirrhosis and an acute episode of hepatic encephalopathy secondary to a clearly identified, potentially reversible precipitating factor, does management of the precipitating event alone improve the hepatic encephalopathy without specific treatment?

    such as lactulose, although several other agents such as non absorbable antibiotics are also used. However, in approximately 50% of...

    Research recommendation
    Published
    11 January 2024